3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
46
Recurrence
6
Leukemia, Myeloid, Acute
5
Waldenstrom Macroglobulinemia
2
Smoldering Multiple Myeloma
2
Plasmacytoma
2
Lymphoma, Large B-Cell, Diffuse
2
Immunoglobulin Light-chain Amyloidosis
2
Carcinoma, Non-Small-Cell Lung
2
Various Advanced Cancer
1
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Microsatellite Unstable Colorectal Cancer
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypergammaglobulinemia
1
Hodgkin Disease
1
Amyloidosis
1
Interventions
Melphalan
5
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Cyclophosphamide
3
Tacrolimus
2
pomalidomide
1
ixazomib
1
elotuzumab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
carmustine, poliferprosan 20 drug combination
1
carfilzomib
1
auricularum
1
Stem Cell Transplantation
1
Sirolimus
1
Panobinostat
1
Lenalidomide
1
High-Throughput Screening Assays
1
Gemcitabine
1
Filgrastim
1
Etoposide
1
Dexamethasone
1
Cytarabine
1
Carmustine
1
Calcium Dobesilate
1
Busulfan
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Plasma Cell
×
daratumumab
×
Clear all
No trials found.